Last Price
0.17
Today's Change
-0.128 (42.95%)
Day's Change
0.168 - 0.238
Trading Volume
31,686,594
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Brent Ness Mr. Brent Ness
Full Time Employees: 4 4
IPO Date: 2022-04-22 2022-04-22
CIK: 0001635077 0001635077
ISIN: US6551872012 US6551872012
CUSIP: 655187102 655187102
Beta: 0.40 0.40
Last Dividend: 0.00 0.00
Dcf Diff: 4.58 4.58
Dcf: -2.28 -2.28
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.